🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II study to determine the safety, tolerability and to ide...
Status
Terminated
Location
The Cancer Institute of New Jersey
Start Date
2007-11
Trial ID
NCT00780143
Treatments Being Tested
The main objective of this study is to evaluate the incidence of post-COVID...
Status
Completed
Location
Hospital Universitari Germans Trias i Pujol
Start Date
2022-01-25
Trial ID
NCT05121740
Treatments Being Tested
This is a multi-center, open-label, single arm, non-comparative phase II tr...
Status
Terminated
Location
CHRU de Lille - Hôpital Claude Huriez
Start Date
2017-05-08
Trial ID
NCT03117361
Treatments Being Tested
This is an open-label, Phase II Clinical Trial of Aplidin® (plitidepsin) in...
Status
Completed
Location
Mayo Clinic
Start Date
2010-07
Trial ID
NCT01149681
Treatments Being Tested
Prospective, multicenter, phase II clinical trial to determine the efficacy...
Status
Terminated
Location
Northwestern University Medical School
Start Date
2016-10-25
Trial ID
NCT03070964
Treatments Being Tested
Liposarcomas are soft tissue sarcomas most frequent. We distinguish three s...
Status
Terminated
Location
Centre Oscar Lambret
Start Date
2012-02
Trial ID
NCT01876043
Treatments Being Tested
Study of Plitidepsin in combination with dexamethasone versus dexamethasone...
Status
Completed
Location
1107
Start Date
2010-06
Trial ID
NCT01102426
Treatments Being Tested
Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of Plit...
Status
Completed
Location
The Cancer Institute of New Jersey (CINJ)
Start Date
2008-12
Trial ID
NCT00788099
Treatments Being Tested
Treatment of patients hospitalised for management of moderate COVID-19 infe...
Status
Terminated
Location
Hospital Felicio Rocho
Start Date
2021-06-04
Trial ID
NCT04784559
Treatments Being Tested
This is a phase II study to determine the efficacy following treatment with...
Status
Completed
Location
Jerome Lipper Multiple Myeloma Center - Dept of Medical Oncology - Dana Farber Cancer Institute
Start Date
2005-02
Trial ID
NCT00229203
Treatments Being Tested